Linefor

Pregabalin, the active ingredient in Linefor, is an anticonvulsant presented as a tablet for oral use. It is prescribed to treat neuropathic pain, partial seizures in epilepsy, generalized anxiety disorder, fibromyalgia and chronic pain conditions.

GNH USA supplies Linefor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing full regulatory documentation for import and distribution across multiple continents and ensuring timely delivery to meet patient needs.

Pregabalin is indicated for several neurological and pain‑related conditions.

Neuropathic pain: Reduces pain intensity in diabetic peripheral neuropathy and post‑herpetic neuralgia. Partial seizures (epilepsy): Decreases seizure frequency in adults with focal onset seizures. Generalized anxiety disorder: Alleviates anxiety symptoms in adult patients. Fibromyalgia: Improves pain, sleep quality and overall function in fibromyalgia.

Pregabalin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Weight gain - Blurred vision - Dry mouth

Serious or Rare Side Effects: - Angioedema or severe allergic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Respiratory depression, especially with CNS depressants - Blood dyscrasias such as neutropenia

Before prescribing Linefor, clinicians should consider several precautionary measures to ensure safe use.

Renal impairment: Adjust dose based on creatinine clearance and monitor renal function. Elderly patients: Initiate at lower dose due to increased sensitivity and risk of sedation. History of substance misuse: Monitor for signs of dependence or abuse. Concomitant CNS depressants: Caution for additive sedation and respiratory depression. Pregnancy and lactation: Use only if potential benefit justifies potential risk; data are limited. Store below 25°C: Keep in original packaging, protect from moisture and direct sunlight.

Pregabalin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Opioids: Combined use may cause profound respiratory depression and sedation. - CNS depressants (benzodiazepines, alcohol): Increases risk of excessive sedation, dizziness, and impaired cognition. - ACE inhibitors: May increase risk of angioedema.

Moderate Interactions (Monitor Closely): - Diuretics: May enhance peripheral edema; monitor fluid status. - NSAIDs: Potential additive effect on renal function; monitor kidney parameters. - Antihypertensives: May cause additive hypotensive effect; observe blood pressure.